After closing the season ranked No. 19 in the AP poll with a 22-9 record and reaching the Round of 16 in the NCAA Tournament, Mizzou volleyball has landed three athletes from the transfer portal ...

The acquisition is expected to support the company’s technological advancements and bolster its market positioning. More about United Micro United Microelectronics Corporation (UMC) is a ...

GlaxoSmithKline has agreed a $3.3 billion takeover of US biotech Affinivax, buying a pneumococcal vaccine candidate that is aiming to break into a market that for years has been dominated by ...

Michigan's offensive line room just got a major boost, adding former UCLA offensive line coach Juan Castillo as an analyst. At 65 years old, Castillo brings a wealth of NFL experience and deep ...

The Los Angeles Dodgers have not only re-signed Teoscar Hernandez to bolster their roster but have also added four key players to strengthen their lineup. These new acquisitions aim to support stars ...

Wild Card Series - Detroit Tigers v Houston Astros - Game 2 / Tim Warner/GettyImages The Detroit Tigers shocked the MLB world by making the postseason for the first time since 2014 after being as ...

UNLV's Latest Tight End Transfer, Nick Elksnis / Jeff Blake-Imagn Images UNLV Football has landed a major addition with the commitment of South Carolina transfer tight end Nick Elksnis. The 6’6 ...

In a strategic move, UltraTech Cement is poised to acquire an 8.69% minority stake in Star Cement, purchasing shares from the Meghalaya-based company's promoter, the Chamaria family, for up to Rs 851 ...

Captain Siya Kolisi is one of three Sharks forwards passed fit for Saturday’s Vodacom URC match in Cape Town. No 8 Kolisi (calf injury), hooker Dylan Richardson and lock Emile van Heerden (both ...

Across the 2022 and 2023 seasons, he pitched 119 innings with a 3.18 ERA and 3.57 SIERA. If the Braves are getting that guy, it’ll be another diamond in the rough find for Alex Anthopoulos. On ...

GSK has agreed to acquire Canada’s Bellus Health for around $2 billion, bolting on a late-stage drug candidate for chronic refractory cough. The $14.75-per-share deal will add P2X3 antagonist ...